BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004;23:829-33. [PMID: 15361721 DOI: 10.1097/01.inf.0000136868.91756.80] [Cited by in Crossref: 241] [Cited by in F6Publishing: 199] [Article Influence: 13.4] [Reference Citation Analysis]
Number Citing Articles
1 Mcneil JC, Hulten KG, Mason EO, Kaplan SL. Serotype 19A is the Most Common Streptococcus pneumoniae Isolate in Children With Chronic Sinusitis. Pediatric Infectious Disease Journal 2009;28:766-8. [DOI: 10.1097/inf.0b013e3181a24557] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Klein JO. Otitis Externa, Otitis Media, and Mastoiditis. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2010. pp. 831-7. [DOI: 10.1016/b978-0-443-06839-3.00057-6] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Deng X, Church D, Vanderkooi OG, Low DE, Pillai DR. Streptococcus pneumoniae infection: a Canadian perspective. Expert Review of Anti-infective Therapy 2014;11:781-91. [DOI: 10.1586/14787210.2013.814831] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
4 Kawano T, Hirano T, Kodama S, Mitsui MT, Ahmed K, Nishizono A, Suzuki M. Pili play an important role in enhancing the bacterial clearance from the middle ear in a mouse model of acute otitis media with Moraxella catarrhalis. Pathog Dis 2013;67:119-31. [PMID: 23620157 DOI: 10.1111/2049-632X.12025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Kung YH, Chiu NC, Lee KS, Chang L, Huang DT, Huang FY, Hsieh YC, Huang LM, Chi H. Bacterial etiology of acute otitis media in the era prior to universal pneumococcal vaccination in Taiwanese children. J Microbiol Immunol Infect 2014;47:239-44. [PMID: 24080520 DOI: 10.1016/j.jmii.2013.08.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
6 Kawai K, Adil EA, Barrett D, Manganella J, Kenna MA. Ambulatory Visits for Otitis Media before and after the Introduction of Pneumococcal Conjugate Vaccination. The Journal of Pediatrics 2018;201:122-127.e1. [DOI: 10.1016/j.jpeds.2018.05.047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
7 Haggard M. Otitis media: Prospects for prevention. Vaccine 2008;26:G20-4. [DOI: 10.1016/j.vaccine.2008.11.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
8 Leibovitz E. Acute otitis media in children aged less than 2 years: drug treatment issues. Paediatr Drugs 2006;8:337-46. [PMID: 17154641 DOI: 10.2165/00148581-200608060-00002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
9 Mizrahi A, Cohen R, Varon E, Bonacorsi S, Bechet S, Poyart C, Levy C, Raymond J. Non typable-Haemophilus influenzae biofilm formation and acute otitis media. BMC Infect Dis 2014;14:400. [PMID: 25037572 DOI: 10.1186/1471-2334-14-400] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
10 Taylor S, Marchisio P, Vergison A, Harriague J, Hausdorff WP, Haggard M. Impact of pneumococcal conjugate vaccination on otitis media: a systematic review. Clin Infect Dis 2012;54:1765-73. [PMID: 22423134 DOI: 10.1093/cid/cis292] [Cited by in Crossref: 96] [Cited by in F6Publishing: 88] [Article Influence: 9.6] [Reference Citation Analysis]
11 Al-Mazrou KA, Shibl AM, Kandeil W, Pirçon JY, Marano C. A prospective, observational, epidemiological evaluation of the aetiology and antimicrobial susceptibility of acute otitis media in Saudi children younger than 5years of age. J Epidemiol Glob Health 2014;4:231-8. [PMID: 25107659 DOI: 10.1016/j.jegh.2014.03.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
12 Block SL, Doern GV, Pfaller MA. Oral β-lactams in the treatment of acute otitis media. Diagnostic Microbiology and Infectious Disease 2007;57:S19-30. [DOI: 10.1016/j.diagmicrobio.2007.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Somech I, Dagan R, Givon-Lavi N, Porat N, Raiz S, Leiberman A, Puterman M, Peled N, Greenberg D, Leibovitz E. Distribution, dynamics and antibiotic resistance patterns of Streptococcus pneumoniae serotypes causing acute otitis media in children in southern Israel during the 10 year-period before the introduction of the 7-valent pneumococcal conjugate vaccine. Vaccine 2011;29:4202-9. [PMID: 21497634 DOI: 10.1016/j.vaccine.2011.03.103] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
14 Ostberg KL, Russell MW, Murphy TF. Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae. Mucosal Immunol 2009;2:63-73. [PMID: 19079335 DOI: 10.1038/mi.2008.70] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
15 Cober MP, Johnson CE. Otitis media: review of the 2004 treatment guidelines. Ann Pharmacother 2005;39:1879-87. [PMID: 16174784 DOI: 10.1345/aph.1G190] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
16 Lucas AH, Apicella MA, Taylor CE. Carbohydrate moieties as vaccine candidates. Clin Infect Dis 2005;41:705-12. [PMID: 16080094 DOI: 10.1086/432582] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
17 Whitney CG, Moore MR. Direct and Indirect Effectiveness and Safety of Pneumococcal Conjugate Vaccine in Practice. In: Siber GR, Klugman KP, Helena Mäkelä P, editors. Pneumococcal Vaccines. Washington: ASM Press; 2008. pp. 351-68. [DOI: 10.1128/9781555815820.ch24] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Koelman DLH, van Kassel MN, Bijlsma MW, Brouwer MC, van de Beek D, van der Ende A. Changing Epidemiology of Bacterial Meningitis Since Introduction of Conjugate Vaccines: 3 Decades of National Meningitis Surveillance in The Netherlands. Clin Infect Dis 2021;73:e1099-107. [PMID: 33247582 DOI: 10.1093/cid/ciaa1774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Black S, Eskola J, Whitney C, Shinefield H. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines. Vaccines. Elsevier; 2008. pp. 531-67. [DOI: 10.1016/b978-1-4160-3611-1.50027-1] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
20 Leibovitz E. The effect of vaccination on Streptococcus pneumoniae resistance. Curr Infect Dis Rep 2008;10:182-91. [DOI: 10.1007/s11908-008-0031-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
21 Toltzis P, Jacobs MR. The Epidemiology of Childhood Pneumococcal Disease in the United States in the Era of Conjugate Vaccine Use. Infectious Disease Clinics of North America 2005;19:629-45. [DOI: 10.1016/j.idc.2005.05.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
22 Smith PF, Tsuji B, Booker BM, Forrest A, Bajic S, Kelchlin P, Bhavnani SM, Jones RN, Ambrose PG. Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model. Diagnostic Microbiology and Infectious Disease 2006;56:379-86. [DOI: 10.1016/j.diagmicrobio.2006.06.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
23 Toltzis P, Dul M, O'riordan MA, Jacobs MR, Blumer J. Serogroup 19 Pneumococci Containing Both mef and erm Macrolide Resistance Determinants in an American City. Pediatric Infectious Disease Journal 2006;25:19-24. [DOI: 10.1097/01.inf.0000195784.27503.f0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
24 Schachern PA, Tsuprun V, Wang B, Apicella MA, Cureoglu S, Paparella MM, Juhn SK. Effect of lipooligosaccharide mutations of Haemophilus influenzae on the middle and inner ears. Int J Pediatr Otorhinolaryngol 2009;73:1757-60. [PMID: 19853312 DOI: 10.1016/j.ijporl.2009.09.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
25 Kordeluk S, Orgad R, Kraus M, Puterman M, Kaplan DM, Novak L, Dagan R, Leibovitz E. Acute mastoiditis in children under 15 years of age in Southern Israel following the introduction of pneumococcal conjugate vaccines: A 4-year retrospective study (2009–2012). International Journal of Pediatric Otorhinolaryngology 2014;78:1599-604. [DOI: 10.1016/j.ijporl.2014.07.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
26 Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother 2009;63:511-9. [PMID: 19174454 DOI: 10.1093/jac/dkn538] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
27 Lockhart SP, Hackell JG, Fritzell B. Pneumococcal conjugate vaccines: emerging clinical information and its implications. Expert Review of Vaccines 2014;5:553-64. [DOI: 10.1586/14760584.5.4.553] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
28 McClure CA, Ford MW, Wilson JB, Aramini JJ. Pneumococcal conjugate vaccination in Canadian infants and children younger than five years of age: Recommendations and expected benefits. Can J Infect Dis Med Microbiol 2006;17:19-26. [PMID: 18418479 DOI: 10.1155/2006/835768] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
29 del Castillo Martín F, Baquero Artigao F, de la Calle Cabrera T, López Robles M, Ruiz Canela J, Alfayate Miguelez S, Moraga Llop F, Cilleruelo Ortega M, Calvo Rey C. Documento de consenso sobre etiología, diagnóstico y tratamiento de la otitis media aguda. Anales de Pediatría 2012;77:345.e1-8. [DOI: 10.1016/j.anpedi.2012.05.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
30 Murphy TF. Haemophilus Species (Including H. influenzae and Chancroid). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2010. pp. 2911-9. [DOI: 10.1016/b978-0-443-06839-3.00225-3] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
31 Brook I, Gober AE. Bacteriology of spontaneously draining acute otitis media in children before and after the introduction of pneumococcal vaccination. Pediatr Infect Dis J 2009;28:640-2. [PMID: 19561428 DOI: 10.1097/INF.0b013e3181975221] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
32 Murphy TF. Current and Future Prospects for a Vaccine for Nontypeable Haemophilus influenzae. Curr Infect Dis Rep 2009;11:177-82. [PMID: 19366559 DOI: 10.1007/s11908-009-0027-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
33 Bingen E, Cohen R, Jourenkova N, Gehanno P. Epidemiologic study of conjunctivitis-otitis syndrome. Pediatr Infect Dis J 2005;24:731-2. [PMID: 16094231 DOI: 10.1097/01.inf.0000172939.13159.3b] [Cited by in Crossref: 41] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
34 Groth C, Thomsen RW, Ovesen T. Association of pneumococcal conjugate vaccination with rates of ventilation tube insertion in Denmark: population-based register study. BMJ Open 2015;5:e007151. [PMID: 26048205 DOI: 10.1136/bmjopen-2014-007151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
35 Hong W, Khampang P, Erbe C, Kumar S, Taylor SR, Kerschner JE. Nontypeable Haemophilus influenzae inhibits autolysis and fratricide of Streptococcus pneumoniae in vitro. Microbes Infect 2014;16:203-13. [PMID: 24269704 DOI: 10.1016/j.micinf.2013.11.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
36 Starner TD, Shrout JD, Parsek MR, Appelbaum PC, Kim G. Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms. Antimicrob Agents Chemother 2008;52:137-45. [PMID: 17954687 DOI: 10.1128/AAC.00607-07] [Cited by in Crossref: 61] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
37 Kyd JM, Hotomi M, Kono M, Kurabi A, Pichichero M, Ryan A, Swords WE, Thornton R. Panel 5: Immunology. Otolaryngol Head Neck Surg 2017;156:S63-75. [DOI: 10.1177/0194599816663886] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
38 Long SS. Capsules, Clones, and Curious Events: Pneumococcus under Fire from Polysaccharide Conjugate Vaccine. Clinical Infectious Diseases 2005;41:30-4. [DOI: 10.1086/430608] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
39 Lee MS, Bernstein HH. Immunizations, neonatal jaundice, and animal-induced injuries: . Current Opinion in Pediatrics 2005;17:418-29. [DOI: 10.1097/00008480-200506000-00016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Reinert R, Jacobs MR, Kaplan SL. Pneumococcal disease caused by serotype 19A: Review of the literature and implications for future vaccine development. Vaccine 2010;28:4249-59. [DOI: 10.1016/j.vaccine.2010.04.020] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 8.7] [Reference Citation Analysis]
41 Parra MM, Aguilar GM, Echaniz-aviles G, Rionda RG, de Los Angeles Meza Estrada M, Cervantes Y, Pirçon J, Van Dyke MK, Colindres RE, Hausdorff WP. Bacterial etiology and serotypes of acute otitis media in Mexican children. Vaccine 2011;29:5544-9. [DOI: 10.1016/j.vaccine.2011.04.128] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
42 Ruck RC, Eberly MD. Development of pneumococcal mastoiditis due to multidrug-resistant serotype 19A despite three doses of 13-valent pneumococcal vaccine. International Journal of Pediatric Otorhinolaryngology 2012;76:1849-51. [DOI: 10.1016/j.ijporl.2012.08.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
43 Vergison A, Dagan R, Arguedas A, Bonhoeffer J, Cohen R, Dhooge I, Hoberman A, Liese J, Marchisio P, Palmu AA, Ray GT, Sanders EA, Simões EA, Uhari M, van Eldere J, Pelton SI. Otitis media and its consequences: beyond the earache. The Lancet Infectious Diseases 2010;10:195-203. [DOI: 10.1016/s1473-3099(10)70012-8] [Cited by in Crossref: 201] [Cited by in F6Publishing: 92] [Article Influence: 16.8] [Reference Citation Analysis]
44 Farrell DJ, Klugman KP, Pichichero M. Increased Antimicrobial Resistance Among Nonvaccine Serotypes of Streptococcus pneumoniae in the Pediatric Population After the Introduction of 7-Valent Pneumococcal Vaccine in the United States: . The Pediatric Infectious Disease Journal 2007;26:123-8. [DOI: 10.1097/01.inf.0000253059.84602.c3] [Cited by in Crossref: 165] [Cited by in F6Publishing: 150] [Article Influence: 11.0] [Reference Citation Analysis]
45 Daly KA, Scott Giebink G, Lindgren BR, Knox J, Haggerty BJ, Nordin J, Goetz S, Ferrieri P. Maternal immunization with pneumococcal 9-valent conjugate vaccine and early infant otitis media. Vaccine 2014;32:6948-55. [PMID: 25444821 DOI: 10.1016/j.vaccine.2014.10.060] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
46 Klugman KP, Black S, Dagan R, Malley R, Whitney CG. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines. Vaccines. Elsevier; 2013. pp. 504-41. [DOI: 10.1016/b978-1-4557-0090-5.00032-x] [Cited by in Crossref: 7] [Article Influence: 0.8] [Reference Citation Analysis]
47 Mahjoub-Messai F, Doit C, Mariani-Kurkdjian P, François M, Bingen E. [Epidemiology of acute otitis media caused by Streptococcus pneumoniae: emergence of serotype 19A]. Arch Pediatr 2008;15:1713-6. [PMID: 18926673 DOI: 10.1016/j.arcped.2008.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
48 Vermee Q, Cohen R, Hays C, Varon E, Bonacorsi S, Bechet S, Thollot F, Corrard F, Poyart C, Levy C, Raymond J. Biofilm production by Haemophilus influenzae and Streptococcus pneumoniae isolated from the nasopharynx of children with acute otitis media. BMC Infect Dis 2019;19:44. [PMID: 30634919 DOI: 10.1186/s12879-018-3657-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
49 Sillanpää S, Sipilä M, Hyöty H, Rautiainen M, Laranne J. Antibiotic resistance in pathogens causing acute otitis media in Finnish children. International Journal of Pediatric Otorhinolaryngology 2016;85:91-4. [DOI: 10.1016/j.ijporl.2016.03.037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
50 Casey JR, Block SL, Hedrick J, Almudevar A, Pichichero ME. Comparison of amoxicillin/clavulanic acid high dose with cefdinir in the treatment of acute otitis media. Drugs 2012;72:1991-7. [PMID: 23039319 DOI: 10.2165/11590320-000000000-00000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
51 Dunne EM, Manning J, Russell FM, Robins-Browne RM, Mulholland EK, Satzke C. Effect of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian children. J Clin Microbiol 2012;50:1034-8. [PMID: 22170924 DOI: 10.1128/JCM.06589-11] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
52 Pichichero ME, Kaur R, Casey JR, Xu Q, Almudevar A, Ochs M. Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children. Hum Vaccin Immunother 2012;8:799-805. [PMID: 22495112 DOI: 10.4161/hv.19820] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
53 Jansen AG, Hak E, Veenhoven RH, Damoiseaux RA, Schilder AG, Sanders EA. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev 2009;:CD001480. [PMID: 19370566 DOI: 10.1002/14651858.CD001480.pub3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
54 Gould JM, Matz PS. Otitis media. Pediatr Rev 2010;31:102-16. [PMID: 20194902 DOI: 10.1542/pir.31-3-102] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
55 Fletcher MA, Fritzell B. Brief review of the clinical effectiveness of PREVENAR® against otitis media. Vaccine 2007;25:2507-12. [DOI: 10.1016/j.vaccine.2006.09.027] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
56 Gisselsson-solén M, Melhus Å, Hermansson A. Pneumococcal vaccination in children at risk of developing recurrent acute otitis media - a randomized study: Vaccination of otitis-prone children. Acta Paediatrica 2011;100:1354-8. [DOI: 10.1111/j.1651-2227.2011.02332.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
57 Vergison A. Microbiology of otitis media: a moving target. Vaccine 2008;26 Suppl 7:G5-10. [PMID: 19094935 DOI: 10.1016/j.vaccine.2008.11.006] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 6.1] [Reference Citation Analysis]
58 Verhaegh SJ, Stol K, de Vogel CP, Riesbeck K, Lafontaine ER, Murphy TF, van Belkum A, Hermans PW, Hays JP. Comparative analysis of the humoral immune response to Moraxella catarrhalis and Streptococcus pneumoniae surface antigens in children suffering from recurrent acute otitis media and chronic otitis media with effusion. Clin Vaccine Immunol 2012;19:914-8. [PMID: 22539468 DOI: 10.1128/CVI.05630-11] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
59 Naranjo L, Suarez JA, DeAntonio R, Sanchez F, Calvo A, Spadola E, Rodríguez N, Andrade O, Bertuglia F, Márquez N, Castrejon MM, Ortega-Barria E, Colindres RE. Non-capsulated and capsulated Haemophilus influenzae in children with acute otitis media in Venezuela: a prospective epidemiological study. BMC Infect Dis 2012;12:40. [PMID: 22335965 DOI: 10.1186/1471-2334-12-40] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
60 Leroy M, Cabral H, Figueira M, Bouchet V, Huot H, Ram S, Pelton SI, Goldstein R. Multiple consecutive lavage samplings reveal greater burden of disease and provide direct access to the nontypeable Haemophilus influenzae biofilm in experimental otitis media. Infect Immun 2007;75:4158-72. [PMID: 17517860 DOI: 10.1128/IAI.00318-07] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
61 Littorin N, Rünow E, Ahl J, Resman F, Riesbeck K. Decreased prevalence of Moraxella catarrhalis in addition to Streptococcus pneumoniae in children with upper respiratory tract infection after introduction of conjugated pneumococcal vaccine: a retrospective cohort study. Clin Microbiol Infect 2021;27:630.e1-6. [PMID: 32360778 DOI: 10.1016/j.cmi.2020.04.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Brook I. Current issues in the management of acute bacterial sinusitis in children. International Journal of Pediatric Otorhinolaryngology 2007;71:1653-61. [DOI: 10.1016/j.ijporl.2007.06.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
63 Antao VC, Hausdorff WP. Global Epidemiology of Pneumococcal Disease—New Prospects for Vaccine Control. In: Finn A, Curtis N, Pollard AJ, editors. Hot Topics in Infection and Immunity in Children V. New York: Springer US; 2009. pp. 19-29. [DOI: 10.1007/978-0-387-79838-7_2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
64 Olwagen CP, Adrian PV, Nunes MC, Madhi SA. Evaluation of the association of pneumococcal conjugate vaccine immunization and density of nasopharyngeal bacterial colonization using a multiplex quantitative polymerase chain reaction assay. Vaccine 2018;36:3278-85. [DOI: 10.1016/j.vaccine.2018.04.068] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
65 Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. The Lancet Infectious Diseases 2008;8:785-95. [DOI: 10.1016/s1473-3099(08)70281-0] [Cited by in Crossref: 174] [Cited by in F6Publishing: 63] [Article Influence: 12.4] [Reference Citation Analysis]
66 Bergenfelz C, Hakansson AP. Streptococcus pneumoniae Otitis Media Pathogenesis and How It Informs Our Understanding of Vaccine Strategies. Curr Otorhinolaryngol Rep 2017;5:115-24. [PMID: 28616365 DOI: 10.1007/s40136-017-0152-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
67 Arguedas A, Dagan R, Guevara S, Porat N, Soley C, Pérez A, Brilla R. Middle Ear Fluid Streptococcus pneumoniae Serotype Distribution in Costa Rican Children with Otitis Media. Pediatric Infectious Disease Journal 2005;24:631-4. [DOI: 10.1097/01.inf.0000168748.92510.45] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
68 Mika M, Maurer J, Korten I, Allemann A, Aebi S, Brugger SD, Qi W, Frey U, Latzin P, Hilty M. Influence of the pneumococcal conjugate vaccines on the temporal variation of pneumococcal carriage and the nasal microbiota in healthy infants: a longitudinal analysis of a case-control study. Microbiome 2017;5:85. [PMID: 28738889 DOI: 10.1186/s40168-017-0302-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
69 Moon SK, Lim DJ. Intratympanic Gene Delivery of Antimicrobial Molecules in Otitis Media. Curr Allergy Asthma Rep 2015;15:14. [PMID: 26130474 DOI: 10.1007/s11882-015-0517-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
70 Brunton S. Current face of acute otitis media: microbiology and prevalence resulting from widespread use of heptavalent pneumococcal conjugate vaccine. Clin Ther 2006;28:118-23. [PMID: 16490585 DOI: 10.1016/j.clinthera.2006.01.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
71 Pichichero ME. Pathogen shifts and changing cure rates for otitis media and tonsillopharyngitis. Clin Pediatr (Phila) 2006;45:493-502. [PMID: 16893853 DOI: 10.1177/0009922806290102] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
72 Coco AS, Horst MA, Gambler AS. Trends in broad-spectrum antibiotic prescribing for children with acute otitis media in the United States, 1998-2004. BMC Pediatr 2009;9:41. [PMID: 19552819 DOI: 10.1186/1471-2431-9-41] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
73 Block SL, Cifaldi M, Gu Y, Paris MM. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study. Clin Ther 2005;27:786-94. [PMID: 16117986 DOI: 10.1016/j.clinthera.2005.06.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
74 Block SL. Management of Acute Otitis Media in Afebrile Neonates. Pediatr Ann 2012;41:225-8. [DOI: 10.3928/00904481-20120524-04] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
75 Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels J, Schuerman L. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. The Lancet 2006;367:740-8. [DOI: 10.1016/s0140-6736(06)68304-9] [Cited by in Crossref: 509] [Cited by in F6Publishing: 165] [Article Influence: 31.8] [Reference Citation Analysis]
76 Pichichero ME, Casey JR. Comparison of study designs for acute otitis media trials. International Journal of Pediatric Otorhinolaryngology 2008;72:737-50. [DOI: 10.1016/j.ijporl.2008.02.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
77 Daniel M, Gautam S, Scrivener TA, Meller C, Levin B, Curotta J. What effect has pneumococcal vaccination had on acute mastoiditis? J Laryngol Otol 2013;127 Suppl 1:S30-4. [PMID: 23186827 DOI: 10.1017/S0022215112002654] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
78 Kempf M, Varon E, Lepoutre A, Gravet A, Baraduc R, Brun M, Chardon H, Cremniter J, Croizé J, Dalmay F, Demachy MC, Fosse T, Grelaud C, Hadou T, Hamdad F, Koeck JL, Luce S, Mermond S, Patry I, Péchinot A, Raymond J, Ros A, Segonds C, Soullié B, Tandé D, Vergnaud M, Vernet-Garnier V, Wallet F, Gutmann L, Ploy MC, Lanotte P. Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network. Clin Microbiol Infect 2015;21:35-42. [PMID: 25636925 DOI: 10.1016/j.cmi.2014.08.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
79 Karki G, Kumar Mandal P. Synthetic directions towards capsular polysaccharide of Streptococcus pneumoniae serotype 18C. Tetrahedron Letters 2019;60:151153. [DOI: 10.1016/j.tetlet.2019.151153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
80 Olarte L, Hulten KG, Lamberth L, Mason EO, Kaplan SL. Impact of the 13-valent Pneumococcal Conjugate Vaccine on Chronic Sinusitis Associated With Streptococcus pneumoniae in Children. Pediatric Infectious Disease Journal 2014;33:1033-6. [DOI: 10.1097/inf.0000000000000387] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 2.1] [Reference Citation Analysis]
81 Murphy TF, Bakaletz LO, Kyd JM, Watson B, Klein DL. Vaccines for otitis media: proposals for overcoming obstacles to progress. Vaccine 2005;23:2696-702. [PMID: 15780715 DOI: 10.1016/j.vaccine.2004.12.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
82 Ivády B, Pásztor M. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated from middle ear fluids of children aged 0–24 months with acute otitis media. Orvosi Hetilap 2009;150:935-41. [DOI: 10.1556/oh.2009.28567] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
83 . Announcement: 2005 Certifying Examination in Pediatric Infectious Diseases. Pediatric Infectious Disease Journal 2004;23:841. [DOI: 10.1097/01.inf.0000138453.32886.a6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
84 Dobay O, Amyes SG, Nagy K. The effect of the 7-valent conjugate vaccine (PCV7) on the incidence of pneumococcal infections world-wide. Reviews in Medical Microbiology 2008;19:79-85. [DOI: 10.1097/mrm.0b013e3283299fa8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
85 Si A, Misra AK. Concise Synthesis of the Phosphoglycerylated Tetrasaccharide Repeating Unit of the Capsular Polysaccharide of Streptococcus pneumoniae Serotype 11 A. ChemistrySelect 2017;2:11771-4. [DOI: 10.1002/slct.201702500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
86 Wiertsema SP, Corscadden KJ, Mowe EN, Zhang G, Vijayasekaran S, Coates HL, Mitchell TJ, Thomas WR, Richmond PC, Kirkham LA. IgG responses to Pneumococcal and Haemophilus influenzae protein antigens are not impaired in children with a history of recurrent acute otitis media. PLoS One 2012;7:e49061. [PMID: 23152850 DOI: 10.1371/journal.pone.0049061] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
87 Barkai G, Greenberg D, Givon-Lavi N, Dreifuss E, Vardy D, Dagan R. Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis 2005;11:829-37. [PMID: 15963276 DOI: 10.3201/eid1106.050198] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
88 Clarke C, Bakaletz LO, Ruiz-Guiñazú J, Borys D, Mrkvan T. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage. Expert Rev Vaccines 2017;16:1-14. [PMID: 28571504 DOI: 10.1080/14760584.2017.1333905] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
89 Kwambana-Adams B, Hanson B, Worwui A, Agbla S, Foster-Nyarko E, Ceesay F, Ebruke C, Egere U, Zhou Y, Ndukum M, Sodergren E, Barer M, Adegbola R, Weinstock G, Antonio M. Rapid replacement by non-vaccine pneumococcal serotypes may mitigate the impact of the pneumococcal conjugate vaccine on nasopharyngeal bacterial ecology. Sci Rep 2017;7:8127. [PMID: 28811633 DOI: 10.1038/s41598-017-08717-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
90 Van Dyke MK, Pirçon JY, Cohen R, Madhi SA, Rosenblüt A, Macias Parra M, Al-Mazrou K, Grevers G, Lopez P, Naranjo L, Pumarola F, Sonsuwan N, Hausdorff WP. Etiology of Acute Otitis Media in Children Less Than 5 Years of Age: A Pooled Analysis of 10 Similarly Designed Observational Studies. Pediatr Infect Dis J 2017;36:274-81. [PMID: 27918383 DOI: 10.1097/INF.0000000000001420] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 4.2] [Reference Citation Analysis]
91 Gladstone RA, Jefferies JM, Faust SN, Clarke SC. Continued control of pneumococcal disease in the UK – the impact of vaccination. Journal of Medical Microbiology 2011;60:1-8. [DOI: 10.1099/jmm.0.020016-0] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
92 DeMuri G, Wald ER. Acute bacterial sinusitis in children. Pediatr Rev 2013;34:429-37; quiz 437. [PMID: 24085791 DOI: 10.1542/pir.34-10-429] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
93 Wiertsema SP, Kirkham LA, Corscadden KJ, Mowe EN, Bowman JM, Jacoby P, Francis R, Vijayasekaran S, Coates HL, Riley TV, Richmond P. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule. Vaccine 2011;29:5163-70. [PMID: 21621576 DOI: 10.1016/j.vaccine.2011.05.035] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 6.5] [Reference Citation Analysis]
94 Dagan R, Pelton S, Bakaletz L, Cohen R. Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease. Lancet Infect Dis 2016;16:480-92. [PMID: 27036355 DOI: 10.1016/S1473-3099(15)00549-6] [Cited by in Crossref: 83] [Cited by in F6Publishing: 35] [Article Influence: 13.8] [Reference Citation Analysis]
95 Pelton SI. Otitis media: re-evaluation of diagnosis and treatment in the era of antimicrobial resistance, pneumococcal conjugate vaccine, and evolving morbidity. Pediatr Clin North Am 2005;52:711-28, v-vi. [PMID: 15925659 DOI: 10.1016/j.pcl.2005.02.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
96 Rodgers GL, Arguedas A, Cohen R, Dagan R. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine 2009;27:3802-10. [PMID: 19446378 DOI: 10.1016/j.vaccine.2009.04.021] [Cited by in Crossref: 94] [Cited by in F6Publishing: 77] [Article Influence: 7.2] [Reference Citation Analysis]
97 Bhetwal N, Mcconaghy JR. The Evaluation and Treatment of Children with Acute Otitis Media. Primary Care: Clinics in Office Practice 2007;34:59-70. [DOI: 10.1016/j.pop.2006.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
98 Baquero-artigao F, del Castillo F. La otitis media aguda en la era de la vacunación antineumocócica. Enfermedades Infecciosas y Microbiología Clínica 2008;26:505-9. [DOI: 10.1016/s0213-005x(08)72780-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
99 Pichichero ME, Doern GV, Kuti JL, Nicolau DP. Probability of Achieving Requisite Pharmacodynamic Exposure for Oral β-Lactam Regimens against Haemophilus influenzae in Children: . Pediatric Drugs 2008;10:391-7. [DOI: 10.2165/0148581-200810060-00006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
100 Alter SJ, Vidwan NK, Sobande PO, Omoloja A, Bennett JS. Common childhood bacterial infections. Curr Probl Pediatr Adolesc Health Care 2011;41:256-83. [PMID: 22005120 DOI: 10.1016/j.cppeds.2011.06.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
101 Brockson ME, Novotny LA, Jurcisek JA, McGillivary G, Bowers MR, Bakaletz LO. Respiratory syncytial virus promotes Moraxella catarrhalis-induced ascending experimental otitis media. PLoS One 2012;7:e40088. [PMID: 22768228 DOI: 10.1371/journal.pone.0040088] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
102 Intakorn P, Sonsuwan N, Noknu S, Moungthong G, Pirçon JY, Liu Y, Van Dyke MK, Hausdorff WP. Haemophilus influenzae type b as an important cause of culture-positive acute otitis media in young children in Thailand: a tympanocentesis-based, multi-center, cross-sectional study. BMC Pediatr 2014;14:157. [PMID: 24947736 DOI: 10.1186/1471-2431-14-157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
103 van Dongen TM, Venekamp RP, Wensing AM, Bogaert D, Sanders EA, Schilder AG. Acute otorrhea in children with tympanostomy tubes: prevalence of bacteria and viruses in the post-pneumococcal conjugate vaccine era. Pediatr Infect Dis J 2015;34:355-60. [PMID: 25764097 DOI: 10.1097/INF.0000000000000595] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
104 Briles DE, Paton JC, Swiatlo E, Crain MJ. Pneumococcal Vaccines. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI, editors. Gram-Positive Pathogens. Washington: ASM Press; 2006. pp. 289-98. [DOI: 10.1128/9781555816513.ch24] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
105 Abdelnour A, Arguedas A, Dagan R, Soley C, Porat N, Mercedes Castrejon M, Ortega-Barria E, Colindres R, Pirçon JY, DeAntonio R, Van Dyke MK. Etiology and antimicrobial susceptibility of middle ear fluid pathogens in Costa Rican children with otitis media before and after the introduction of the 7-valent pneumococcal conjugate vaccine in the National Immunization Program: acute otitis media microbiology in Costa Rican children. Medicine (Baltimore) 2015;94:e320. [PMID: 25590837 DOI: 10.1097/MD.0000000000000320] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
106 Best EJ, Walls T, Souter M, Neeff M, Anderson T, Salkeld L, Ahmad Z, Mahadevan M, Walker C, Murdoch D, Mills N. Pneumococcal vaccine impact on otitis media microbiology: A New Zealand cohort study before and after the introduction of PHiD-CV10 vaccine. Vaccine 2016;34:3840-7. [DOI: 10.1016/j.vaccine.2016.05.041] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
107 Biesbroek G, Wang X, Keijser BJ, Eijkemans RM, Trzciński K, Rots NY, Veenhoven RH, Sanders EA, Bogaert D. Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children. Emerg Infect Dis 2014;20:201-10. [PMID: 24447437 DOI: 10.3201/eid2002.131220] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 8.4] [Reference Citation Analysis]
108 Yang P, Zhang J, Peng A. The pharyngeal carriage of Haemophilus influenzae among healthy population in China: a systematic review and meta-analysis. BMC Infect Dis 2019;19:547. [PMID: 31226950 DOI: 10.1186/s12879-019-4195-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
109 Forgie S, Zhanel G, Robinson J; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Management of acute otitis media. Paediatrics & Child Health 2009;14:457-60. [DOI: 10.1093/pch/14.7.457] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
110 Khan MN, Pichichero ME. The host immune dynamics of pneumococcal colonization: implications for novel vaccine development. Hum Vaccin Immunother 2014;10:3688-99. [PMID: 25668673 DOI: 10.4161/21645515.2014.979631] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
111 Kilpi T, Schuerman L. Acute Otitis Media and Its Sequelae. In: Siber GR, Klugman KP, Helena Mäkelä P, editors. Pneumococcal Vaccines. Washington: ASM Press; 2008. pp. 301-15. [DOI: 10.1128/9781555815820.ch20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
112 Schuerman L, Borys D, Hoet B, Forsgren A, Prymula R. Prevention of otitis media: Now a reality? Vaccine 2009;27:5748-54. [DOI: 10.1016/j.vaccine.2009.07.070] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
113 Whitney CG. Can Vaccines Control Resistance? The Example of Pneumococcal Conjugate Vaccine. Infectious Diseases in Clinical Practice 2006;14:S24-30. [DOI: 10.1097/01.idc.0000230541.02089.8c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
114 Katz A, Leibovitz E, Timchenko VN, Greenberg D, Porat N, Peled N, Dagan R, Ossipov IB. Antibiotic susceptibility, serotype distribution and vaccine coverage of nasopharyngeal and oropharyngeal Streptococcus pneumoniae in a day-care centre in St. Petersburg, Russia. Scand J Infect Dis 2007;39:293-8. [PMID: 17454891 DOI: 10.1080/00365540600987741] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
115 Leibovitz E, Broides A, Greenberg D, Newman N. Current management of pediatric acute otitis media. Expert Review of Anti-infective Therapy 2014;8:151-61. [DOI: 10.1586/eri.09.112] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
116 Block SL. Searching for the Holy Grail of acute otitis media. Arch Dis Child 2006;91:959-61. [PMID: 17119072 DOI: 10.1136/adc.2006.097063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
117 Gisselsson-Solén M, Bylander A, Wilhelmsson C, Hermansson A, Melhus A. The Binax NOW test as a tool for diagnosis of severe acute otitis media and associated complications. J Clin Microbiol 2007;45:3003-7. [PMID: 17634299 DOI: 10.1128/JCM.00299-07] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
118 Lee H, Choi EH, Lee HJ. Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines. Korean J Pediatr 2014;57:55-66. [PMID: 24678328 DOI: 10.3345/kjp.2014.57.2.55] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
119 Pichichero ME, Casey JR, Hoberman A, Schwartz R. Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006. Clin Pediatr (Phila) 2008;47:901-6. [PMID: 18559884 DOI: 10.1177/0009922808319966] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
120 Briles DE, Paton JC, Mukerji R, Swiatlo E, Crain MJ. Pneumococcal Vaccines. Microbiol Spectr 2019;7. [PMID: 31858954 DOI: 10.1128/microbiolspec.GPP3-0028-2018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
121 Ben-shimol S, Givon-lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R. Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media. Clin Infect Dis 2016;63:611-8. [DOI: 10.1093/cid/ciw347] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 10.8] [Reference Citation Analysis]
122 Dinleyici EC, Yargic ZA. Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era. Expert Review of Vaccines 2014;7:1367-94. [DOI: 10.1586/14760584.7.9.1367] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
123 Dicks LM, Knoetze H, van Reenen CA. Otitis Media: A Review, with a Focus on Alternative Treatments. Probiotics Antimicrob Proteins 2009;1:45-59. [PMID: 26783131 DOI: 10.1007/s12602-009-9008-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
124 Ozturk GZ, Toprak D, Sagsoz O, Ardic C. Knowledge, Attitude and Practice of Family Physicians on Antimicrobial Therapy for Acute Respiratory Tract Infections - A Study from Istanbul, Turkey. Euras J Fam Med 2021;10:49-55. [DOI: 10.33880/ejfm.2021100202] [Reference Citation Analysis]
125 Clementi CF, Murphy TF. Non-typeable Haemophilus influenzae invasion and persistence in the human respiratory tract. Front Cell Infect Microbiol 2011;1:1. [PMID: 22919570 DOI: 10.3389/fcimb.2011.00001] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 5.9] [Reference Citation Analysis]
126 Benninger MS, Manz R. The impact of vaccination on rhinosinusitis and otitis media. Curr Allergy Asthma Rep 2010;10:411-8. [PMID: 20737301 DOI: 10.1007/s11882-010-0139-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
127 Xie J, Juliao PC, Gilsdorf JR, Ghosh D, Patel M, Marrs CF. Identification of new genetic regions more prevalent in nontypeable Haemophilus influenzae otitis media strains than in throat strains. J Clin Microbiol 2006;44:4316-25. [PMID: 17005745 DOI: 10.1128/JCM.01331-06] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
128 Shaikh N, Wald ER, Jeong JH, Kurs-Lasky M, Bowen A, Flom LL, Hoberman A. Predicting response to antimicrobial therapy in children with acute sinusitis. J Pediatr 2014;164:536-41. [PMID: 24367985 DOI: 10.1016/j.jpeds.2013.11.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
129 McGrath LJ, Becker-Dreps S, Pate V, Brookhart MA. Trends in antibiotic treatment of acute otitis media and treatment failure in children, 2000-2011. PLoS One 2013;8:e81210. [PMID: 24324680 DOI: 10.1371/journal.pone.0081210] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
130 Zielnik-Jurkiewicz B, Bielicka A. Antibiotic resistance of Streptococcus pneumoniae in children with acute otitis media treatment failure. Int J Pediatr Otorhinolaryngol 2015;79:2129-33. [PMID: 26454530 DOI: 10.1016/j.ijporl.2015.09.030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
131 Singh A, Dutta AK. Pneumococcal Vaccines - How Many Serotypes are Enough? Indian J Pediatr 2018;85:47-52. [PMID: 28887787 DOI: 10.1007/s12098-017-2449-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
132 Sierra A, Lopez P, Zapata MA, Vanegas B, Castrejon MM, Deantonio R, Hausdorff WP, Colindres RE. Non-typeable Haemophilus influenzae and Streptococcus pneumoniae as primary causes of acute otitis media in colombian children: a prospective study. BMC Infect Dis 2011;11:4. [PMID: 21208431 DOI: 10.1186/1471-2334-11-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
133 Couloigner V, Levy C, François M, Bidet P, Hausdorff WP, Pascal T, Boucherat M, Bingen E, Mariani P, Pierrot S, Bille E, Carbonnelle E, Varon E, Cohen R. Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levels. Pediatr Infect Dis J 2012;31:154-8. [PMID: 21983212 DOI: 10.1097/INF.0b013e3182357c8d] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
134 Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, Campos J, Virji M, Pelton SI. Nontypeable Haemophilus influenzae as a Pathogen in Children. Pediatric Infectious Disease Journal 2009;28:43-8. [DOI: 10.1097/inf.0b013e318184dba2] [Cited by in Crossref: 160] [Cited by in F6Publishing: 88] [Article Influence: 12.3] [Reference Citation Analysis]
135 Brook I, Foote PA, Hausfeld JN. Frequency of recovery of pathogens causing acute maxillary sinusitis in adults before and after introduction of vaccination of children with the 7-valent pneumococcal vaccine. Journal of Medical Microbiology 2006;55:943-6. [DOI: 10.1099/jmm.0.46346-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
136 Block SL, Busman TA, Paris MM, Bukofzer S. Comparison of Five-Day Cefdinir Treatment with Ten-Day Low Dose Amoxicillin/Clavulanate Treatment for Acute Otitis Media. Pediatric Infectious Disease Journal 2004;23:834-8. [DOI: 10.1097/01.inf.0000137574.28711.c4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
137 Fortanier AC, Venekamp RP, Boonacker CW, Hak E, Schilder AG, Sanders EA, Damoiseaux RA. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev 2014;:CD001480. [PMID: 24696098 DOI: 10.1002/14651858.CD001480.pub4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
138 Leibovitz E, Asher E, Piglansky L, Givon-Lavi N, Satran R, Raiz S, Slovik Y, Leiberman A, Dagan R. Is bilateral acute otitis media clinically different than unilateral acute otitis media? Pediatr Infect Dis J 2007;26:589-92. [PMID: 17596799 DOI: 10.1097/INF.0b013e318060cc19] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
139 Langereis JD, de Jonge MI. Invasive Disease Caused by Nontypeable Haemophilus influenzae. Emerg Infect Dis 2015;21:1711-8. [PMID: 26407156 DOI: 10.3201/eid2110.150004] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]
140 Guevara S, Soley C, Arguedas A, Porat N, Dagan R. Seasonal Distribution of Otitis Media Pathogens Among Costa Rican Children. Pediatric Infectious Disease Journal 2008;27:12-6. [DOI: 10.1097/inf.0b013e3181468643] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
141 Yu S, Yao K, Shen X, Zhang W, Liu X, Yang Y. Serogroup distribution and antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae among Beijing children with upper respiratory infections (2000–2005). Eur J Clin Microbiol Infect Dis 2008;27:649-55. [DOI: 10.1007/s10096-008-0481-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
142 Barkai G, Leibovitz E, Givon-Lavi N, Dagan R. Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media. Pediatr Infect Dis J 2009;28:466-71. [PMID: 19504729 DOI: 10.1097/inf.0b013e3181950c74] [Cited by in Crossref: 60] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
143 Alonso M, Marimon JM, Ercibengoa M, Pérez-Yarza EG, Pérez-Trallero E. Dynamics of Streptococcus pneumoniae serotypes causing acute otitis media isolated from children with spontaneous middle-ear drainage over a 12-year period (1999-2010) in a region of northern Spain. PLoS One 2013;8:e54333. [PMID: 23349853 DOI: 10.1371/journal.pone.0054333] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
144 Segal N, Leibovitz E, Dagan R, Leiberman A. Acute otitis media-diagnosis and treatment in the era of antibiotic resistant organisms: updated clinical practice guidelines. Int J Pediatr Otorhinolaryngol 2005;69:1311-9. [PMID: 15955573 DOI: 10.1016/j.ijporl.2005.05.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
145 Van Eldere J, Slack MP, Ladhani S, Cripps AW. Non-typeable Haemophilus influenzae, an under-recognised pathogen. Lancet Infect Dis 2014;14:1281-92. [PMID: 25012226 DOI: 10.1016/S1473-3099(14)70734-0] [Cited by in Crossref: 191] [Cited by in F6Publishing: 99] [Article Influence: 23.9] [Reference Citation Analysis]
146 Hau I, Levy C, Caeymaex L, Cohen R. Impact of Pneumococcal Conjugate Vaccines on Microbial Epidemiology and Clinical Outcomes of Acute Otitis Media. Pediatr Drugs 2014;16:1-12. [DOI: 10.1007/s40272-013-0044-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
147 Dunne EM, Smith-Vaughan HC, Robins-Browne RM, Mulholland EK, Satzke C. Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination. Vaccine 2013;31:2333-42. [PMID: 23523773 DOI: 10.1016/j.vaccine.2013.03.024] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
148 Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2010;29:304-9. [PMID: 19935445 DOI: 10.1097/INF.0b013e3181c1bc48] [Cited by in Crossref: 99] [Cited by in F6Publishing: 120] [Article Influence: 8.3] [Reference Citation Analysis]
149 Giufrè M, Daprai L, Cardines R, Bernaschi P, Ravà L, Accogli M, Raponi M, Garlaschi ML, Ciofi degli Atti ML, Cerquetti M. Carriage of Haemophilus influenzae in the oropharynx of young children and molecular epidemiology of the isolates after fifteen years of H. influenzae type b vaccination in Italy. Vaccine 2015;33:6227-34. [PMID: 26440924 DOI: 10.1016/j.vaccine.2015.09.082] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
150 Mackenzie GA, Carapetis JR, Leach AJ, Morris PS. Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination. BMC Pediatr 2009;9:14. [PMID: 19228431 DOI: 10.1186/1471-2431-9-14] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
151 Pérez-Trallero E, García-de-la-Fuente C, García-Rey C, Baquero F, Aguilar L, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Respiratory Pathogens. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob Agents Chemother 2005;49:1965-72. [PMID: 15855520 DOI: 10.1128/AAC.49.5.1965-1972.2005] [Cited by in Crossref: 106] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
152 Klugman KP, Dagan R, Malley R, Whitney CG. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 773-815.e18. [DOI: 10.1016/b978-0-323-35761-6.00045-6] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
153 Holder RC, Kirse DJ, Evans AK, Peters TR, Poehling KA, Swords WE, Reid SD. One third of middle ear effusions from children undergoing tympanostomy tube placement had multiple bacterial pathogens. BMC Pediatr 2012;12:87. [PMID: 22741759 DOI: 10.1186/1471-2431-12-87] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
154 Le T, Rovers MM, Veenhoven RH, Sanders EAM, Schilder AGM. Effect of pneumococcal vaccination on otitis media with effusion in children older than 1 year. Eur J Pediatr 2007;166:1049-52. [DOI: 10.1007/s00431-006-0379-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
155 Doern GV. Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance. Expert Rev Anti Infect Ther 2006;4:821-35. [PMID: 17140358 DOI: 10.1586/14787210.4.5.821] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
156 Talbird SE, Taylor TN, Caporale J, Ismaila AS, Gomez J. Residual economic burden of Streptococcus pneumoniae- and nontypeable Haemophilus influenzae- associated disease following vaccination with PCV-7: A multicountry analysis. Vaccine 2010;28:G14-22. [DOI: 10.1016/j.vaccine.2010.06.080] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
157 Yadav MK, Chae SW, Song JJ. In VitroStreptococcus pneumoniae Biofilm Formation and In Vivo Middle Ear Mucosal Biofilm in a Rat Model of Acute Otitis Induced by S. pneumoniae. Clin Exp Otorhinolaryngol 2012;5:139-44. [PMID: 22977710 DOI: 10.3342/ceo.2012.5.3.139] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
158 Shaikh N, Hoberman A. Update: acute otitis media. Pediatr Ann 2010;39:28-33. [PMID: 20151622 DOI: 10.3928/00904481-20091222-03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
159 Fallon RM, Kuti JL, Doern GV, Girotto JE, Nicolau DP. Pharmacodynamic Target Attainment of Oral β-Lactams for the Empiric Treatment of Acute Otitis Media in Children: . Pediatric Drugs 2008;10:329-35. [DOI: 10.2165/00148581-200810050-00006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
160 Stamboulidis K, Chatzaki D, Poulakou G, Ioannidou S, Lebessi E, Katsarolis I, Sypsa V, Tsakanikos M, Kafetzis D, Tsolia MN. The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J 2011;30:551-5. [PMID: 21297521 DOI: 10.1097/INF.0b013e31821038d9] [Cited by in Crossref: 55] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
161 Greenberg D, Hoffman S, Leibovitz E, Dagan R. Acute Otitis Media in Children: Association with Day Care Centers ??? Antibacterial Resistance, Treatment, and Prevention. Pediatric Drugs 2008;10:75-83. [DOI: 10.2165/00148581-200810020-00002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
162 Hilty M, Qi W, Brugger SD, Frei L, Agyeman P, Frey PM, Aebi S, Mühlemann K. Nasopharyngeal microbiota in infants with acute otitis media. J Infect Dis 2012;205:1048-55. [PMID: 22351941 DOI: 10.1093/infdis/jis024] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
163 Funaki T, Inoue E, Miyairi I. Clinical characteristics of the patients with bacteremia due to Moraxella catarrhalis in children: a case-control study. BMC Infect Dis 2016;16:73. [PMID: 26861621 DOI: 10.1186/s12879-016-1408-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
164 Hedrick JA. Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins. Expert Rev Anti Infect Ther 2010;8:15-21. [PMID: 20014898 DOI: 10.1586/eri.09.115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
165 Benninger MS. Acute bacterial rhinosinusitis and otitis media: changes in pathogenicity following widespread use of pneumococcal conjugate vaccine. Otolaryngol Head Neck Surg 2008;138:274-8. [PMID: 18312870 DOI: 10.1016/j.otohns.2007.11.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
166 Resman F, Ristovski M, Ahl J, Forsgren A, Gilsdorf JR, Jasir A, Kaijser B, Kronvall G, Riesbeck K. Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains. Clin Microbiol Infect 2011;17:1638-45. [PMID: 21054663 DOI: 10.1111/j.1469-0691.2010.03417.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 76] [Article Influence: 7.7] [Reference Citation Analysis]
167 Whitby PW, Seale TW, Morton DJ, Stull TL. Antisera Against Certain Conserved Surface-Exposed Peptides of Nontypeable Haemophilus influenzae Are Protective. PLoS One 2015;10:e0136867. [PMID: 26390432 DOI: 10.1371/journal.pone.0136867] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
168 Martin JM, Hoberman A, Paradise JL, Barbadora KA, Shaikh N, Bhatnagar S, Shope T, Block SL, Haralam MA, Kurs-Lasky M, Colborn DK, Green M. Emergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media. Pediatr Infect Dis J 2014;33:e286-90. [PMID: 24911895 DOI: 10.1097/INF.0000000000000445] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
169 Martin JM, Hoberman A, Shaikh N, Shope T, Onika Bhatnagar S, Block SL, Haralam MA, Kurs-Lasky M, Green M. Changes Over Time in Nasopharyngeal Colonization in Children Under 2 Years of Age at the Time of Diagnosis of Acute Otitis Media (1999-2014). Open Forum Infect Dis 2018;5:ofy036. [PMID: 29588912 DOI: 10.1093/ofid/ofy036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
170 Brook I, Gober AE. Frequency of recovery of pathogens from the nasopharynx of children with acute maxillary sinusitis before and after the introduction of vaccination with the 7-valent pneumococcal vaccine. Int J Pediatr Otorhinolaryngol 2007;71:575-9. [PMID: 17267051 DOI: 10.1016/j.ijporl.2006.10.025] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
171 Ho YC, Lee PL, Wang YC, Chen SC, Chen KT. The economic burden of childhood invasive pneumococcal diseases and pneumonia in Taiwan: Implications for a pneumococcal vaccination program. Hum Vaccin Immunother 2015;11:1081-7. [PMID: 25874476 DOI: 10.1080/21645515.2015.1023969] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
172 Pérez-Trallero E, Marimón JM, Alonso M, Ercibengoa M, García-Arenzana JM. Decline and rise of the antimicrobial susceptibility of Streptococcus pneumoniae isolated from middle ear fluid in children: influence of changes in circulating serotypes. Antimicrob Agents Chemother 2012;56:3989-91. [PMID: 22547622 DOI: 10.1128/AAC.00501-12] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
173 Grubb MS, Spaugh DC. Microbiology of acute otitis media, Puget Sound region, 2005-2009. Clin Pediatr (Phila) 2010;49:727-30. [PMID: 20185479 DOI: 10.1177/0009922810361365] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
174 van Gils EJ, Veenhoven RH, Rodenburg GD, Hak E, Sanders EA. Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial. Vaccine 2011;29:7595-8. [DOI: 10.1016/j.vaccine.2011.08.049] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
175 Pichichero ME, Casey JR. Evolving Microbiology and Molecular Epidemiology of Acute Otitis Media in the Pneumococcal Conjugate Vaccine Era. Pediatric Infectious Disease Journal 2007;26:S12-6. [DOI: 10.1097/inf.0b013e318154b25d] [Cited by in Crossref: 38] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
176 Mahadevan M, Navarro-locsin G, Tan H, Yamanaka N, Sonsuwan N, Wang P, Dung NT, Restuti R, Hashim S, Vijayasekaran S. A review of the burden of disease due to otitis media in the Asia-Pacific. International Journal of Pediatric Otorhinolaryngology 2012;76:623-35. [DOI: 10.1016/j.ijporl.2012.02.031] [Cited by in Crossref: 56] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
177 Hoberman A, Paradise JL, Shaikh N, Greenberg DP, Kearney DH, Colborn DK, Rockette HE, Kurs-Lasky M, McEllistrem MC, Zoffel LM, Balentine TL, Barbadora KA, Wald ER. Pneumococcal resistance and serotype 19A in Pittsburgh-area children with acute otitis media before and after introduction of 7-valent pneumococcal polysaccharide vaccine. Clin Pediatr (Phila) 2011;50:114-20. [PMID: 21098526 DOI: 10.1177/0009922810384259] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
178 Massa HM, Cripps AW, Lehmann D. Otitis media: viruses, bacteria, biofilms and vaccines. Med J Aust 2009;191:S44-9. [PMID: 19883356 DOI: 10.5694/j.1326-5377.2009.tb02926.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
179 de Carvalho CX, Kipnis A, Thörn L, de Andrade JG, Pimenta F, Brandileone MCDC, Zanella RC, Flannery B, Sgambatti S, Andrade AL. Carriage of Haemophilus influenzae among Brazilian children attending day care centers in the era of widespread Hib vaccination. Vaccine 2011;29:1438-42. [DOI: 10.1016/j.vaccine.2010.12.045] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
180 Prymula R, Kriz P, Kaliskova E, Pascal T, Poolman J, Schuerman L. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age. Vaccine 2009;28:71-8. [PMID: 19818722 DOI: 10.1016/j.vaccine.2009.09.113] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 5.7] [Reference Citation Analysis]
181 Murphy TF, Bakaletz LO, Smeesters PR. Microbial interactions in the respiratory tract. Pediatr Infect Dis J 2009;28:S121-6. [PMID: 19918134 DOI: 10.1097/INF.0b013e3181b6d7ec] [Cited by in Crossref: 108] [Cited by in F6Publishing: 59] [Article Influence: 9.0] [Reference Citation Analysis]
182 Agrawal A, Murphy TF. Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era. J Clin Microbiol 2011;49:3728-32. [PMID: 21900515 DOI: 10.1128/JCM.05476-11] [Cited by in Crossref: 145] [Cited by in F6Publishing: 77] [Article Influence: 13.2] [Reference Citation Analysis]
183 Hallström T, Riesbeck K. Haemophilus influenzae and the complement system. Trends Microbiol 2010;18:258-65. [PMID: 20399102 DOI: 10.1016/j.tim.2010.03.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
184 Murphy TF. Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now. Clin Vaccine Immunol 2015;22:459-66. [PMID: 25787137 DOI: 10.1128/CVI.00089-15] [Cited by in Crossref: 69] [Cited by in F6Publishing: 41] [Article Influence: 9.9] [Reference Citation Analysis]
185 Dinleyici EC, Yargic ZA. Pneumococcal conjugated vaccine: PHiD-CV. Expert Review of Anti-infective Therapy 2014;7:1063-74. [DOI: 10.1586/eri.09.84] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
186 Pottumarthy S, Sader HS, Fritsche TR, Jones RN. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis? Diagn Microbiol Infect Dis 2005;53:225-31. [PMID: 16257168 DOI: 10.1016/j.diagmicrobio.2005.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
187 Hsieh YC, Chiu CH, Chang KY, Huang YC, Chen CJ, Kuo CY, Chen PY, Hwang KP, Lin TY. The impact of the heptavalent pneumococcal conjugate vaccine on risk factors for Streptococcus pneumoniae carriage in children. Pediatr Infect Dis J 2012;31:e163-8. [PMID: 22592521 DOI: 10.1097/INF.0b013e31825cb9f9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
188 Alekshun M, Levy S. Commensals upon us. Biochemical Pharmacology 2006;71:893-900. [DOI: 10.1016/j.bcp.2005.12.040] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
189 Glanz JM, McClure DL, O'Leary ST, Narwaney KJ, Magid DJ, Daley MF, Hambidge SJ. Parental decline of pneumococcal vaccination and risk of pneumococcal related disease in children. Vaccine 2011;29:994-9. [PMID: 21145372 DOI: 10.1016/j.vaccine.2010.11.085] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
190 Murphy TF. Vaccine development for Moraxella catarrhalis : rationale, approaches and challenges. Expert Review of Vaccines 2014;8:655-8. [DOI: 10.1586/erv.09.28] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
191 Cunningham M, Guardiani E, Kim HJ, Brook I. Otitis media. Future Microbiology 2012;7:733-53. [DOI: 10.2217/fmb.12.38] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
192 Winther B, Block SL, Reisinger K, Dutkowski R. Impact of oseltamivir treatment on the incidence and course of acute otitis media in children with influenza. Int J Pediatr Otorhinolaryngol 2010;74:684-8. [PMID: 20363510 DOI: 10.1016/j.ijporl.2010.03.024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
193 Holder RC, Kirse DJ, Evans AK, Whigham AS, Peters TR, Poehling KA, Swords WE, Reid SD. Otopathogens Detected in Middle Ear Fluid Obtained during Tympanostomy Tube Insertion: Contrasting Purulent and Non-Purulent Effusions. PLoS One 2015;10:e0128606. [PMID: 26039250 DOI: 10.1371/journal.pone.0128606] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
194 Levy C, Thollot F, Corrard F, Lécuyer A, Martin P, Boucherat M, Koskas M, Romain O, Goldrey M, Hausdorff W, Cohen R. Otite moyenne aiguë en pédiatrie ambulatoire : caractéristiques épidémiologiques et cliniques après l’introduction du vaccin antipneumococcique conjugué 7 valent (PCV7). Archives de Pédiatrie 2011;18:712-8. [DOI: 10.1016/j.arcped.2011.03.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
195 van der Linden M, Reinert RR. Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany. Eur J Clin Microbiol Infect Dis 2010;29:749-54. [PMID: 20432051 DOI: 10.1007/s10096-010-0945-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
196 Fletcher MA, Fritzell B. Pneumococcal conjugate vaccines and otitis media: an appraisal of the clinical trials. Int J Otolaryngol 2012;2012:312935. [PMID: 22701486 DOI: 10.1155/2012/312935] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
197 Navne JE, Koch A, Slotved HC, Andersson M, Melbye M, Ladefoged K, Børresen M. Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children. Int J Circumpolar Health 2017;76:1309504. [PMID: 28467237 DOI: 10.1080/22423982.2017.1309504] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
198 Jardine A, Menzies RI, Deeks SL, Patel MS, McIntyre PB. The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia. Pediatr Infect Dis J 2009;28:761-5. [PMID: 19546840 DOI: 10.1097/INF.0b013e31819e9bc5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 7] [Article Influence: 2.9] [Reference Citation Analysis]
199 Kordeluk S, Kraus M, Leibovitz E. Challenges in the Management of Acute Mastoiditis in Children. Curr Infect Dis Rep 2015;17. [DOI: 10.1007/s11908-015-0479-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
200 Ziv O, Kraus M, Holcberg R, Dinur AB, Kordeluk S, Kaplan D, Rosenblatt HN, Ben-Shimol S, Greenberg D, Leibovitz E. Acute otitis media in infants younger than two months of age: Epidemiologic and microbiologic characteristics in the era of pneumococcal conjugate vaccines. Int J Pediatr Otorhinolaryngol 2019;119:123-30. [PMID: 30703661 DOI: 10.1016/j.ijporl.2019.01.031] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
201 Pettigrew MM, Alderson MR, Bakaletz LO, Barenkamp SJ, Hakansson AP, Mason KM, Nokso-Koivisto J, Patel J, Pelton SI, Murphy TF. Panel 6: Vaccines. Otolaryngol Head Neck Surg 2017;156:S76-87. [PMID: 28372533 DOI: 10.1177/0194599816632178] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
202 Dagan R. Appropriate treatment of acute otitis media in the era of antibiotic resistance. Paediatr Drugs 2010;12 Suppl 1:3-9. [PMID: 20590168 DOI: 10.2165/11538720-S0-000000000-00002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
203 Wald ER, Demuri GP. COMMENTARY: Antibiotic Recommendations for Acute Otitis Media and Acute Bacterial Sinusitis in 2013—The Conundrum. Pediatric Infectious Disease Journal 2013;32:641-3. [DOI: 10.1097/inf.0b013e3182868cc8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
204 Chiu NC, Lin HY, Hsu CH, Huang FY, Lee KS, Chi H. Epidemiological and microbiological characteristics of culture-proven acute otitis media in Taiwanese children. J Formos Med Assoc 2012;111:536-41. [PMID: 23089688 DOI: 10.1016/j.jfma.2011.07.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
205 Klugman KP, Mcgee L. Resurgence of the Multiresistant Pneumococcus in the United States: A Commentary. Pediatric Infectious Disease Journal 2007;26:473-4. [DOI: 10.1097/inf.0b013e3180517b8b] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]